Clinical Trials Logo

Muscular Atrophy clinical trials

View clinical trials related to Muscular Atrophy.

Filter by:

NCT ID: NCT05219487 Recruiting - Clinical trials for Spinal Muscular Atrophy

Investigating NMJ Defects in SMA Following Central and Peripheral SMN Restoration

Start date: October 13, 2021
Phase:
Study type: Observational

This is an observational study to investigate the improvement of NMJ defects in adult patients with SMA following treatment with Risdiplam. Eligible patients will have received treatment with daily oral Risdiplam after receiving approval through their commercial insurance or drug assistance program. All subjects will be evaluated at one visit. Eligible subjects must have been receiving risdiplam for at least 12 months.

NCT ID: NCT05216666 Recruiting - Muscle Weakness Clinical Trials

The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

HSS
Start date: May 11, 2022
Phase: N/A
Study type: Interventional

Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.

NCT ID: NCT05211986 Recruiting - Muscle Atrophy Clinical Trials

Safety and Tolerability of IMMUNA(IMM01-STEM) in Patients With Muscle Atrophy Related to Knee Osteoarthritis.

Start date: September 13, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

An open-label dose escalation study to assess the safety and tolerability of IMMUNA(IMM01-STEM) in participants with muscle atrophy related to knee osteoarthritis

NCT ID: NCT05210205 Completed - Weight Loss Clinical Trials

Physiological Response to Protein and Energy-enhanced Food Products During Winter Military Training

Start date: March 13, 2022
Phase: N/A
Study type: Interventional

Soldiers commonly lose muscle mass during training and combat operations that produce large energy deficits (i.e., calories burned > calories consumed). Developing new combat ration products that increase energy intake (i.e., energy dense foods) or the amount and quality of protein consumed (i.e., essential amino acid [EAA] content) may prevent muscle breakdown and stimulate muscle repair and muscle maintenance during unavoidable energy deficit. The primary objective of this study is to determine the effects of prototype recovery food products that are energy dense or that provide increased amounts of EAAs (anabolic component of dietary protein) on energy balance, whole-body net protein balance, and indices of physiological status during strenuous winter military training.

NCT ID: NCT05206838 Recruiting - Muscle Weakness Clinical Trials

Achilles Tendon for the Treatment of Gluteus Medius Insufficiency

HLS
Start date: June 29, 2022
Phase: N/A
Study type: Interventional

Residual limping after total hip arthroplasty is a serious complication that lacks effective treatment. The purpose of this study is to evaluate a surgical treatment for residual limping and compare its results with non-surgical treatment. Our hypothesis is that surgical treatment followed by physiotherapy increases hip function and reduces limping compared with non-surgical treatment with physiotherapy alone.

NCT ID: NCT05206253 Completed - Muscle Atrophy Clinical Trials

Effectiveness of Egg Versus Whey Protein Powder During Resistance Training

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

Consumption of whole eggs has recently been shown to stimulate muscle protein synthesis to a greater degree than consumption of egg whites after a resistance training session. It is theorized that the egg yoke contains bio-active nutrients that enhance the protein provided by egg whites. The study will evaluate the effect of whole egg powder compared to whey protein powder and placebo over 12 weeks of resistance training in men and women who are participating in resistance training programs.

NCT ID: NCT05204017 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

CAPTURE ALS
Start date: September 12, 2021
Phase:
Study type: Observational

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.

NCT ID: NCT05198466 Completed - COVID-19 Clinical Trials

Electrical Stimulation for Critically Ill Post-Covid-19 Patients

Phase II
Start date: August 18, 2021
Phase: Phase 2
Study type: Interventional

Unfortunately, hospital-acquired weakness is highly prevalent among COVID-19 hospitalized patients, who often require prolonged bed-rest or paralytics for an extended period of time in order to maintain oxygenation. Prolonged bed rest has been associated with pronounced loss of muscle mass that can exceed 10% over the 1st week, which leads to functional impairment and complications post-hospital discharge. Physical therapy and in-hospital mobility program may reduce the incident of hospital-acquired weakness, but they are often impractical for COVID-19 patients. In particular, conventional mobility programs are challenging for those who are being treated in an intensive Care Unit. The purpose of this study is to test feasibility and proof-of-concept effectiveness of daily use of lower extremity electrical stimulation (EE) therapy, as a practical solution to address lower extremity muscle deconditioning, to address chronic consequences of COVID-19 including hospital-acquired weakness.

NCT ID: NCT05187260 Recruiting - Clinical trials for Spinal Muscular Atrophy

Antisense Oligonucleotide for Spinal Muscular Atrophy

Start date: January 1, 2022
Phase:
Study type: Observational

This is a longitudinal, multiple-center, observational study of patients genetically confirmed chromosome 5q SMA to monitor the efficacy, safety, tolerability of SPINRAZA® (nusinersen) for up to 24 months.

NCT ID: NCT05184023 Active, not recruiting - Clinical trials for Anterior Cruciate Ligament Injuries

The Effect of PEMF for Patients With Quadriceps Muscle Weakness After ACLR

Start date: September 1, 2021
Phase: N/A
Study type: Interventional

In Hong Kong, over 3000 Anterior Cruciate Ligament Reconstructions (ACLR) are performed each year in order to restore knee function after an ACL injury. The ultimate goal of ACLR is to fulfil the return-to-play (RTP) criteria. Despite successful surgery and a demanding rehabilitation process, some athletes still fail to comply to RTP. For those who achieve RTP, 23% of those who return to their sports would suffer a second ACL injury. Quadriceps muscle strength is one of the key determinants for a patient's successful return- to-play after ACLR. Quadriceps muscle atrophy can persist beyond the completion of the rehabilitation program in almost half the patients and the reason behind this is still unknown. Therefore, there is need to find a more effective way to increase quadriceps strength. There are emerging evidences showing that pulsed electromagnetic field (PEMF) can modulate mitochondrial activities for muscle gain. PEMF exposure on top of regular exercise training may promote muscle regeneration and tissue healing. This study aims to conduct a double-blinded, randomized controlled trial to investigate the effects of PEMF treatment during the late postoperative period on quadriceps muscle strength in ACL injured patient. Muscle endurance could only be investigated in late postoperative period. The investigators hypothesize that PEMF treatment is effective to reduce muscle weakness and promote gain in quadriceps muscle strength in ACLR patients. Based on the aim of this study, adult patients (aged 18-30) with a unilateral ACL injury, total quadriceps muscle volume is equal or morn than 7% deficit on involved leg compared with uninvolved leg, sporting injury with a Tegner score of 7+, both knees without a history of injury/prior surgery will be recruited. To estimate the improvement of patients, Isokinetic muscle assessment, ultrasound imaging and MRI for quadriceps muscle thickness, self-reported outcomes with questionnaires, KT-1000 for knee laxity and biomechanical analysis, Xtreme CT for Bone mineral density will be performed. To investigate the mechanism of PEMF therapy on increasing quadriceps strength, samples of blood serum will be draw before and after intervention.